Anton RF, O'Malley SS, Mann KF, Silverman BL. New Reduced Drinking Goals in Alcohol Pharmacotherapy Trials-A Novel Public-Private Effort and FDA Approval Process. JAMA Psychiatry. 2025 Sep 17. [Epub ahead of print]
Bach P. [Not Available]. MMW Fortschr Med. 2025 167(5):31.
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Antidepressants, relapse-prevention medications and both combined to reduce alcohol-related hospitalizations in individuals with severe alcohol use disorder. Eur Arch Psychiatry Clin Neurosci. 2025 Mar 12. [Epub ahead of print]
Bach P, Franck J, Hällgren J, Widing H, Gissler M, Westman J. Pharmacological Treatments in Alcohol Use Disorder and Risk of Alcohol-Related Hospitalizations: A Register Study. Acta Psychiatr Scand. 2025 152(2):94-103. Epub 2025 Mar 17.
Baumann G, Fischer R, Reinhard I, Hoffmann S, Kiefer F, Leménager T, Bach P. Investigating decision-making under risk in pathological gambling using a virtual slot machine - a pilot eye-tracking study. Eur Addict Res. 2025 Aug 26. [Epub ahead of print] :1-28.
Bekier N, Frischknecht U, Eidenmueller K, Grimm F, Bach P, Stenger M, Kiefer F, Hermann D. Does cannabis use substitute for opioids? A preliminary exploratory survey in opioid maintenance patients. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):565-572. Epub 2024 Mar 19.
Biondi-Zoccai G, Lauretti A, Agewall S, Andres E, Audisio RA, Bhatt DL, Citerio G, Drezner JA, Eggermont A, Erol C, Ersche KD, Ferriero G, Heusch G, Indolfi C, Insel PA, Lavie CJ, La Vecchia C, Maffulli N, Montecucco F, Moliterno DJ, Nattel S, O'Kane P, Oliaro E, Pelliccia A, Picard M, Pozzilli P, Quaglia F, Riha RL, Sarkar R, Scicchitano P, Teboul JL, Stahel HT, Wold LE, Booz GW, Artificial Intelligence in Medical Publishing (AIMPub) Working Group AIMPub. Perspectives on artificial intelligence in medical publishing: a survey of medical journal editors. J Cardiovasc Pharmacol. 2025 Jul 22. [Epub ahead of print]
Chestnykh D, Kalinichenko LS, von Hörsten S, Kornhuber J, Müller CP. The mirror preference test: A reverse translational approach to study anomalous subjective experience in rats. Brain Res Bull. 2025 222:111247. Epub 2025 Feb 5.
Chestnykh D, Mühle C, Schumacher F, Kalinichenko LS, Löber S, Gmeiner P, Alzheimer C, von Hörsten S, Kleuser B, Uebe S, Ekici AB, Gulbins E, Kornhuber J, Jin HK, Bae JS, Lourdusamy A, Müller CP. Acid sphingomyelinase activity suggests a new antipsychotic pharmaco-treatment strategy for schizophrenia. Mol Psychiatry. 2025 30(7):2891-2906. Epub 2025 Jan 17.
Eidenmueller K, Hoffmann S, Kammler-Sücker K, Wenger L, Mazza M, Mühle C, Stenger M, Meixner G, Kiefer F, Lenz B. Reactivity to Smoking Cues in a Social Context: Virtual Reality Experiment. JMIR Form Res. 2025 9:e71285.
Gerhardt S, Kroth M, Seeger A, Schmitt R, Fritz H, Diring L, Shevchenko Y, Ersche KD, Feld G, Vollstädt-Klein S. Increasing the smoking cessation success rate by enhancing improvement of self-control through sleep-amplified memory consolidation: protocol of a randomized controlled, functional magnetic resonance study. BMC Psychol. 2025 13(1):157.
Gihl J, Zacharias N, Hoffmann S, Thürauf N, Schaller G, Winterer G, Koopmann A, Kiefer F, Kornhuber J, Mühle C, Lenz B. No Relevant Associations Between Markers of Smoking Behaviour and Plasma Progesterone Concentrations: Findings From a Sex-Stratified Cohort Study. Addict Biol. 2025 30(8):e70071.
Graczyk MM, Cardinal RN, Lim TV, Nigro S, Mak E, Ersche KD. Deconstructing delay discounting in human cocaine addiction using computational modelling and neuroimaging. Biol Psychiatry Cogn Neurosci Neuroimaging. 2025 10(8):856-864. Epub 2024 Dec 26.
Grundinger N, Andreas M, Lohner V, Schneider S, Mons U, Vollstädt-Klein S. From Smoking to Vaping: The Motivation for E-Cigarette Use at the Neurobiological Level - An fMRI Study. Nicotine Tob Res. 2025 27(7):1236-1246. Epub 2024 Nov 21.
John U, Rumpf HJ, Hoffmann S, Meyer C, Kiefer F. [Long-term courses of alcohol dependence]. Nervenarzt. 2025 96(1):31-36. Epub 2024 Aug 21.
Kalinichenko LS, Zoicas I, Bienia AM, Bühner C, Robinson J, Kütemeyer J, Labonte A, Raveendran T, Warth L, Smaga I, Filip M, Eulenburg V, Rhein C, Fejtova A, Gulbins E, Kornhuber J, Müller CP. Brain acid sphingomyelinase controls addiction-related behaviours in a sex-specific way. Neurobiol Dis. 2025 206:106800.
Landhaeusser V, Bazhanov A, Lenz B, Kammler-Sücker K, Prager Loos R, Chojnowska A, Meixner G. A gamified approach for alcohol use disorder therapy in virtual reality : a randomized trial. IEEE ICHI. 2025 13th International Conference on Healthcare Informatics:598-609.
Lenz B, Derntl B. Sex-sensitive and gender-sensitive care for patients with mental disorders. Lancet Psychiatry. 2025 12(4):244-246. Epub 2024 Oct 24.
Lim TV, Cardinal RN, Ziauddeen H, Regenthal R, Sahakian BJ, Robbins TW, Ersche KD. Atomoxetine reduces decisional impulsivity in human cocaine addiction. Biol Psychiatry. 2025 97(6):627-636. Epub 2024 Oct 29.
Mestermann S, Fasching PA, Beckmann MW, Hemetsberger J, Kratz O, Moll GH, Bailer M, Kornhuber J, Lenz B, Eichler A, IMAC-Mind Consortium . What's About Adolescent Online Gamers' Mental Health? Psychological and Cortisol-Stress-System Outcomes in Childhood and Adolescence: A Prospective Longitudinal Case-Control Study. Health Sci Rep. 2025 8(8):e71135.
Nayman S, Niedtfeld I, Lenz B, Karabatsiakis A, Schmahl C, Kühner C. Menstrual Cycle Dynamics in Mental Health Demand new Approaches in Psychotherapy and Digital Health. Psychother Psychosom. 2025 Sep 18. [Epub ahead of print] :1-5.
Pfisterer M, Teetzmann A, Vetter S, Baeßler J, Schreckenberger L, Zaiser J, Stenger M, Bach P. CBD attenuates amygdala response to negative emotional stimuli in individuals with alcohol use disorder - a randomized controlled trial. Psychopharmacology (Berl). 2025 Aug 29. [Epub ahead of print]
Pfisterer M, Zimmermann S, Zaiser J, Gerhardt S, Vollstädt-Klein S, Kiefer F, Bach P. Biomarkers in alcohol use disorder - the promise and pitfalls of neuroimaging drug cue reactivity. Biomarkers in neuropsychiatry. 2025 12:100119.
Reinhardt P, Zacharias N, Fislage M, Böhmer J, Hollunder B, Reppmann Z, Wiehe A, Rajwich R, Dominick N, Ritter K, Bajbouj M, Wienker T, Gallinat J, Thürauf N, Kornhuber J, Kiefer F, Wagner M, Tüscher O, Walter H, Winterer G. Machine Learning Classification of Smoking Behaviours-From Social Environment to the Prefrontal Cortex. Addict Biol. 2025 30(8):e70056.
Salamian A, Pagano R, Skonieczna E, Kalinichenko LS, Puchalska M, Yiğit Ünlü G, Gajewska-Woźniak O, Kruashvili L, Grochowicz M, Wojtas B, Gielniewski B, Harda Z, Cały A, Mühle C, Lenz B, Kornhuber J, Lourdusamy A, Havekes R, Abel T, Müller CP, Radwanska K. Hippocampal Cofilin and CFL1 gene variants are linked to Alcohol Use Disorder phenotypes. Mol Psychiatry. 2025 Sep 11. [Epub ahead of print]
Stüben N, Muscheidt R, Kiefer F, Soyka M. Web-based interventions for treatment-seeking individuals with hazardous alcohol consumption: analysis of clinical characteristics and motives for abstinence. Alcohol Alcohol. 2025 60(3)
Trent S, Abdullah MH, Parwana K, Valdivieso MA, Hassan Z, Müller CP. Fear conditioning: Insights into learning, memory and extinction and its relevance to clinical disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2025 138:111310. Epub 2025 Mar 6.
Türkmen C, Machunze N, Lee AM, Bougelet E, Ludin NM, de Cates AN, Vollstädt-Klein S, Bach P, Kiefer F, Andreas JB, Kamphuis J, Schoevers RA, Emslie GJ, Hetrick SE, Viechtbauer W, van Dalfsen JH. Systematic Review and Meta-Analysis: The Association Between Newer Generation Antidepressants and Insomnia in Children and Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2025 64(10):1148-1164. Epub 2025 Jan 17.
Türkmen C, Schneider CL, Viechtbauer W, Bolstad I, Chakravorty S, Miller MB, Kallestad H, Angenete GW, Johann AF, Feige B, Spiegelhalder K, Riemann D, Vedaa Ø, Pallesen S, Hertenstein E. Cognitive behavioral therapy for insomnia across the spectrum of alcohol use disorder: A systematic review and meta-analysis. Sleep Med Rev. 2025 80:102049. Epub 2025 Jan 11.
Vetter S, Schnabel S, Reichl M, Sirignano L, Grinevich V, Koopmann A, Spanagel R, Kiefer F, Sommer WH, Bach P. Intranasal oxytocin blunts amygdala response to negative affective stimuli in males and females with alcohol use disorder: a randomized controlled cross-over trial. Psychopharmacology (Berl). 2025 242(9):1995-2007. Epub 2025 Mar 31.
Vetter S, Weinberg J, Thomas BC, Kirchner M, Thalmann P, Klose C, Pfisterer M, Kölsch T, Oesterle S, Vollstädt-Klein S, Koopmann A, Lenz B, Kiefer F, Link T, Bach P. Investigation of the combined effects of cannabidiol plus naltrexone on alcohol craving in alcohol dependence: study protocol of a phase II randomised, double-blind, placebo-controlled, parallel-group trial - ICONICplus Trial. BMJ Open. 2025 15(8):e106348.
Wenzel JG, Reichert M, Zech H, Wedemeyer F, Deeken F, Spitta G, Bach P, Lenz B, Ebner-Priemer UW, Kiefer F, Rapp MA, Walter H, Heinz A, Banaschewski T. One-year ecological momentary assessment of alcohol use, mood, and stress among individuals with alcohol use disorder during SARS-CoV-2 pandemics: a gender-specific reflection. Eur Arch Psychiatry Clin Neurosci. 2025 275(2):451-461. Epub 2024 Nov 19.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Bach P, Koopmann A. Glucose intake reduces alcohol craving and amplifies habituation to cue-induced brain activation in male patients with alcohol use disorder: A randomized, placebo-controlled crossover study examining male and female patients with AUD. Psychoneuroendocrinology. 2025 177:107456.
Wetzel L, Hoffmann S, Reinhard I, Riegler A, Pourbaix M, Ardern I, Link T, Vollstädt-Klein S, Lenz B, Kiefer F, Koopmann A, Bach P. Glucose Intake Reduces Craving in Patients with Alcohol Use Disorder Depending on Insulin Response. Eur Addict Res. 2025 31(4):251-263.
Wetzel L, Ohly O, Reichl M, Lenz B. Fetale Alkoholspektrumstörungen bei Erwachsenen. Psych up2date. 2025 19:389-405.
Wieland N, Larsen H, Wiers RW, Kühling J, Brunner W, Frischknecht U. Motivational Interviewing in Addiction Services: An Exploratory Study of Training Needs. Eur Addict Res. 2025 31(3):169-178.
Witkiewitz K, Anton RF, O'Malley SS, Hasin DS, Silverman BL, Aldridge A, Mann KF, Alcohol Clinical Trials Initiative (ACTIVE Group) . Reductions in World Health Organization Risk Drinking Levels as a Primary Efficacy End Point for Alcohol Clinical Trials: A Review. JAMA Psychiatry. 2025 Sep 17. [Epub ahead of print]
Zaiser J, Hoffmann S, Zimmermann S, Gessner T, Deck M, Bekier N, Abel M, Radler P, Langejürgen J, Lenz B, Vollstädt-Klein S, Stallkamp J, Kirschbaum C, Kiefer F, Bach P. Individual stress reactivity predicts alcohol craving and alcohol consumption in alcohol use disorder in experimental and real-life settings. Transl Psychiatry. 2025 15(1):226.
Zimmermann S, Teetzmann A, Baeßler J, Schreckenberger L, Zaiser J, Pfisterer M, Stenger M, Bach P. Acute cannabidiol administration reduces alcohol craving and cue-induced nucleus accumbens activation in individuals with alcohol use disorder: the double-blind randomized controlled ICONIC trial. Mol Psychiatry. 2025 30(6):2612-2619. Epub 2024 Dec 12.
Zimmermann US, Plickert C, Lüdecke C, Stuppe M, Rosenbeiger C, Krisam Y, Link T, Keller J, Bühler G, Scholz-Hehn D, Havemann-Reinecke U, Wedekind D, Luderer M, Spreer M. [Patient and quality characteristics in the treatment with disulfiram (Antabus) in the German "Network for Alcohol Aversive Pharmacotherapy"]. Nervenarzt. 2025 96(2):159-165.